Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C62H88N13O14P.C10H12N5O3.Co |
| Molecular Weight | 1579.5818 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 17 / 18 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Co+3].[CH2-][C@H]1O[C@H]([C@@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3N.C[C@H](CNC(=O)CC[C@]4(C)[C@@H](CC(N)=O)C5[N-]C4=C(C)C6=NC(=CC7=NC(=C(C)C8=N[C@]5(C)[C@@](C)(CC(N)=O)[C@@H]8CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]7CCC(N)=O)C(C)(C)[C@@H]6CCC(N)=O)OP([O-])(=O)O[C@@H]9[C@@H](CO)O[C@@H]([C@@H]9O)N%10C=NC%11=C%10C=C(C)C(C)=C%11
InChI
InChIKey=OAJLVMGLJZXSGX-NDSREFPTSA-L
InChI=1S/C62H90N13O14P.C10H12N5O3.Co/c1-29-20-39-40(21-30(29)2)75(28-70-39)57-52(84)53(41(27-76)87-57)89-90(85,86)88-31(3)26-69-49(83)18-19-59(8)37(22-46(66)80)56-62(11)61(10,25-48(68)82)36(14-17-45(65)79)51(74-62)33(5)55-60(9,24-47(67)81)34(12-15-43(63)77)38(71-55)23-42-58(6,7)35(13-16-44(64)78)50(72-42)32(4)54(59)73-56;1-4-6(16)7(17)10(18-4)15-3-14-5-8(11)12-2-13-9(5)15;/h20-21,23,28,31,34-37,41,52-53,56-57,76,84H,12-19,22,24-27H2,1-11H3,(H15,63,64,65,66,67,68,69,71,72,73,74,77,78,79,80,81,82,83,85,86);2-4,6-7,10,16-17H,1H2,(H2,11,12,13);/q;-1;+3/p-2/t31-,34-,35-,36-,37+,41-,52-,53-,56?,57+,59-,60+,61+,62+;4-,6-,7+,10-;/m11./s1
| Molecular Formula | C62H89N13O14P |
| Molecular Weight | 1271.4225 |
| Charge | -1 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 13 / 14 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | C10H11N5O3 |
| Molecular Weight | 249.226 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | Co |
| Molecular Weight | 58.933195 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cobamamide is one of the active forms of vitamin B12 that is also known as adenosylcobalamin or dibencozide. This drug is available as a nutritional supplement to prevent the vitamin B12 deficiency. Liposomal formulation of cobamamide was developed for the treatment of atopic dermatitis by a Korean company Hanall Biopharma.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Nitric oxide synthase Sources: https://adisinsight.springer.com/drugs/800033627 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 18:27:34 GMT 2025
by
admin
on
Wed Apr 02 18:27:34 GMT 2025
|
| Record UNII |
F0R1QK73KB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
B03BA04
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
||
|
WHO-VATC |
QB03BA04
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
||
|
DSLD |
1612 (Number of products:7)
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
13870-90-1
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
1142195
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
F0R1QK73KB
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
F0R1QK73KB
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
237-627-6
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
C169859
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
DTXSID1046009
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
DB11191
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
21373
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | RxNorm | ||
|
m3705
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
757791
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
4404
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
1915
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
COBAMAMIDE
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
131635025
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
100000084059
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
SUB06788MIG
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY | |||
|
18408
Created by
admin on Wed Apr 02 18:27:34 GMT 2025 , Edited by admin on Wed Apr 02 18:27:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |